Compare Grand House Mulia Tbk. (HOMI) vs Indofarma Tbk. (INAF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Grand House Mulia Tbk. vs Indofarma Tbk. — how do they compare? Grand House Mulia Tbk. trades at Rp232 (market cap 384.3B, 3.49M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Grand House Mulia Tbk. and Indofarma Tbk. are close in size by market cap. Which is the better fit depends on your goals.
| HOMI | INAF | |
|---|---|---|
Market Cap | 384.3B | 390.51B |
Volume | 3.49M | — |
Lot | 34.89K | — |
Turnover | 796.11M | — |
Average Price | 228.18 | — |
Value | 796.11M | — |
Indicative Equilibrium Price | 232 | — |
Indicative Equilibrium Volume | 110 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Grand House Mulia Tbk.
PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.
Read more on HOMI →About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →
